ArticleMolecular genetics and metabolism2018

Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin.

A Cougnoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.